The Business & Technology Network
Helping Business Interpret and Use Technology
Home
Newswire > Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary
Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary
«  

February

  »
S M T W T F S
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 

Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary

DATE POSTED:February 18, 2026
The Block
Original article

Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.

The Block
Original article
Newswire > Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary

All Rights Reserved. Copyright , Central Coast Communications, Inc.